OTHER INFORMATION
+Added: Trading Plans
+Added: On June 12, 2023 , Todd Franklin Watanabe , President, Chief Executive Officer and Director, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 109,025 shares of the Company’s common stock until September 6, 2024.
Number Description of Document Incorporated by Reference Form Date Number Filed/Furnished Herewith
25 unchanged sentences
ARCUTIS BIOTHERAPEUTICS, INC.
−Removed: May 09, 2023 By:
+Added: August 08, 2023 By:
/s/ Todd Franklin Watanabe
2 unchanged sentences
(Principal Executive Officer)
−Removed: May 09, 2023 By:
+Added: August 08, 2023 By:
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.